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Abstract
Introduction: The provision of efﬁcient dental care to patients with hemostatic disorders is tied to difﬁculties and
problems, such as prolonged bleeding after or during surgical manipulation.
Aim: was to increase the efﬁciency of oral surgery in patients with thrombocytopenia with the use of erbium laser on
different stages of tooth extraction.
Methods: Patients (n ¼ 96) were selected for tooth extraction on an outpatient basis: patients with conﬁrmed thrombocytopenia (age 44 ± 15.4, 19e74) were included in the 1st group, and patients without impaired hemostasis (age 47.6 ±
15.3, 19e81) were included in the 2nd group (p > 0.05). In the 1st group, operation with the use of erbium laser with with a
wavelength of 2490 nm in a noncontact mode was performed in two stages: separation of a circular tooth ligament and
curettage of the socket after tooth extraction. In the 2nd group (control), the treatment was provided according to a
traditional algorithm. Before the operation, the lab blood tests for thrombocytes were performed in both groups;
moreover, for the 1st group, the duration of bleeding and total coagulation were evaluated. In the postoperative period,
pain and edema of soft tissues and hemostasis duration were assessed in both groups.
Results: According to the results of our research, the use of erbium laser in the 1st group allowed us to decrease hemostasis duration compared with the control group of patients (80.9 ± 35.9 and 175 ± 67.5 sec, p < 0.01) and reach the
similar probability of postoperative bleeding after tooth extraction (p < 0.5). Pain and edema of soft tissues in dynamics
after operation were less in the 1st group (p < 0.001).
Conclusion: Application of erbium laser is an up-to-date method that can be successfully used in surgical treatment in
patients with hemostasis failure for bleeding and other postoperative complications prevention and stimulation of the
alveolar epithelialization after tooth extraction.
Keywords: bleeding, erbium laser, hemostasis, platelets, tooth extraction, thrombocytopenia

1. Introduction

C

urrently, there are difﬁculties in providing
dental care to patients with diseases of the
hematopoietic system, including a lack of preventive orientation and planning in treatment,
inadequacy of its quality to modern requirements,
and low level of dental hygiene education and
patient awareness. All these problems dictate the
need to address the issues of providing dental care
to patients with this pathology [1-6].

When performing surgical interventions in patients with impaired platelet hemostasis, in conditions such as thrombocytopenia, thrombocythemia,
and thrombocytopathy, there is a risk of intra- and
postoperative bleeding and hematoma formation,
due to a signiﬁcant decrease or possible increase in
platelet count, or a pathological change in platelet
function [7-9]. First-line drug treatment in patients
with the autoimmune impaired hemostasis alike
primary thrombocytopenia includes the appointment of glucocorticoids or cytostatic medicine,
which can lead to the development of
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immunosuppression and inﬂuence the repair and
regeneration processes, contributing to the occurrence of postoperative inﬂammatory complications
[10-16]. In most cases, dental interventions are
usually carried out after preliminary medical preparation, “under the cover” of such hemostatic drugs
as, for example, cryoprecipitate, freshly frozen blood
plasma and others [17-22]. The development of
effective substitution therapy and nonspeciﬁc drugs
can successfully prevent and treat almost all types of
bleeding, and thereby achieve a qualitatively new
standard of living for hematological patients. However, in urgent cases, it is necessary to provide
surgical dental care without prolonged medical
preparation [23-26].
Laser technologies are now widely used methods
of treatment of diseases and in medicine, also in
dentistry. Dentists can use different lasers according
to their modes and wavelengths for different purposes: Remark: Please replace with “ablation of hard
tissues of tooth; surgery of oral mucosa, particularly
in chronic conditions like ulcers and tissues of
periodontum; endodontic dentistry; and dental implantation.” [27, 28].
Earlier, dentists used only the physiotherapeutic
effect of the low-intensity lasers, but with the
development of medicine, the opportunities of laser
application are also widening. The diode laser is
characterized by the rather high proﬁle of safety
without the damage of the adjunct area besides
target points that allow us to use it even during
tender manipulations in dentistry as endodontics
and periodontics treatment , but it does not show
sufﬁcient antibacterial effect in all cases. In oral
surgery during the last years the use of high intensity
lasers, such as erbium, is considered as an alternative to cutting and rotational instruments but can
lead to some unpleasant outcomes, such as tissue
overheating. Characteristics of appropriate situations
for the use of laser during surgery include the
maintenance of a good sterile zone, avoidance of
active bleeding, avoidance of disturbance of entire
neighborhood structures in the oral cavity. The
decrease in the loss of marginal periodontium and in
the risk of scar formation after using lasers was
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noted, particularly in comparison with the traditional
scalpel techniques [29]. Also, the erbium laser can
create conditions for speeding wound epithelization,
stimulation of local immune system elements and
reduction of pathogenic microorganism activity [30].
Laser technology used in dentistry allows
decreasing the risk of possible complications,
duration of manipulation, the level of patient fear on
dental visit as well as achieving good postoperative
results, which is particularly important for patients
with impaired hemostasis because they are scared
of possible extensive bleeding and need for
hospitalization.
The aim of the study was to increase the efﬁciency
of surgical dental treatment of patients with platelet
hemostasis disorders using laser technologies.

2. Methods
As part of this study, an examination and surgical
treatment of 96 patients requiring surgical dental
care were performed during 6 years since 2014 at the
Department of Dental Surgery of the Institute of
Dentistry of Sechenov University, Moscow, Russia
and Department of Maxillofacial Surgery of Moscow
State Medical Dentistry University.
This study was approved by Local Committee of
Ethics N6 on 02/22/2011, N 14-19 on 11/13/2019
and performed according to the principles outlined
in the Declaration of Helsinki. We received the patients’ consent for using the results of research, Xray, and photos of the operation.
Two groups of patients were formed: in the 1st
group I (n ¼ 48) patients had impaired platelet hemostasis. Surgical dental care for these patients was
provided using an erbium laser with a wavelength
of 2940 nm. The 2nd group (control group, n ¼ 48)
consisted of patients without hemostatic disorders.
Surgical dental treatment was performed using
traditional methods.
Inclusion and exclusion criteria for participant
enrolment in our research are listed in Table 1.
All patients underwent standard dental and
radiological examinations. When examining the oral
cavity, attention was drawn to the presence of foci of

Table 1. The inclusion and exclusion criteria for patients.
Criteria

Inclusion

Exclusion

Age, years
Thrombocytes/mL

>18
Approved thrombocytopenia
(<100)
Permanent
Present
Absent
Good

<18
Reference means

Medical treatment of thrombocytopenia
Indications for oral surgery
Other comorbidities, besides thrombocytopenia
Compliance

Periodical
Present
Bad

chronic infection (carious lesions, complications of
caries), the condition of periodontal tissues, the
presence of hemorrhagic syndrome manifestations
in the oral cavity (bleeding of the mucous membrane, petechiae, and ecchymosis), and oral hygiene
index.
As a laboratory preoperative examination in patients with hemostatic pathology, the following
methods were performed: a common blood test
(hematology), coagulogram and express diagnostic
methods for determination of bleeding time according to Duke (a method that involves a stab
incision in patient's cleaned ﬁnger or earlobe with a
lancet and later, using a timer, the blood is blotted
twice a minute; time is measured in minutes) [31]
and time of total blood coagulation according to
Morawitz (a drop of blood taken from a ﬁnger or
earlobe is applied to a glass slide; turning on the
stopwatch, a thin glass capillary is lowered into a
drop of blood every 20-30 seconds; coagulation time
is determined at the time the ﬁrst thin ﬁlament of
ﬁbrin appears when the capillary is pulled from a
drop of blood) [32].
Patients with platelet hemostasis disorders underwent surgical treatment under local anesthesia
on an outpatient basis and according to indications:
tooth extraction (due to the chronic apical periodontitis or its exacerbation and acute or chronic
pericoronitis with the tooth dystopia, followed by
treatment of the extracted tooth sockets with laser
radiation in a non-contact mode).
In patients with hemostatic disorders, we used an
erbium laser with a wavelength of 2940 nm (Fig.
1A), which can be used when working with both
soft and hard tissues. Among all the operations we
performed, the most frequent was the tooth
extraction.
When working with soft tissues, we used radiation
energy of 300 mJ and a frequency of 10 Hz without
water-air cooling to coagulate the walls of the vessels of soft tissues and ensure hemostasis. Work on
hard tissues was performed by an erbium laser in a
noncontact manner in a pulsed mode, the radiation
energy was 250 mJ and the frequency was 15 Hz
with water-air cooling. When performing tooth extractions, the tooth alveolus was treated with an
erbium laser in the hard tissue mode, and then the
surrounding soft tissues of the adjacent gums and
periodontal ligaments were treated with radiation
from the erbium laser in the corresponding mode
(Fig. 1B-D). This set was chosen according to the
results of our previous experience of treatment of a
patient with the same co-morbidity but in the case
of periostitis [33]. Local hemostatic drugs were not
used; preoperative drug preparation of patients was
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not performed. The control of hemostasis was carried out within 40 minutes after the intervention. In
patients of the control group, surgical treatment was
carried out according to the traditional method,
without the use of laser technology.
On days 1 and 3 of the postoperative period, the
severity of pain was evaluated using a digital rating
scale (Numerical Pain Scale) (0-4 points: 0 indicates
absence of pain, 1 lack of pain, 2-mild pain, 3moderate pain, and 4- severe pain) and visual
assessment of collateral edema (0-4 points: 0 indicates absence of edema, 1 lack of edema, 1 - mild
edema, 2-moderate edema, 3- severe edema). We
supposed the possibility of postoperative bleeding
in points (0 indicates absence of bleeding, and 1
indicates bleeding and requiring treatment).
2.1. Statistics
We checked normality with the Shapiroe
Wilcoxon test and used methods of non-parametric
statistics because of the lack of normality of distributions. We compared the two groups according to
each criterion with the help of ManneWhitney test
imagining that the null hypothesis m0 was not equal
to m1 when m0 “there were no differences between
the groups”. We evaluated the differences in dynamics criteria, pain, and edema with the help of
KruskaleWallis test and the probability of postoperative bleeding in both groups using the chisquare test. We analyzed the strength of correlation
between different criteria and methods of treatment
in both groups with the Pearson correlation coefﬁcient in program R (designed by Ross Ihaka and
Robert Gentleman, licensed in R Foundation, project GNU GPL, 2020, version 3.6.1) with installed
packages ggpubr and ggplot2.

3. Results
The age of patients in both groups was similar and
varied from 19 to 74 years in the 1st group and from
19 to 81 years in the 2nd group (U ¼ 1020.5, p > 0.05).
All patients of the 1st group had anxiety and fear
not only of the upcoming treatment but also of the
examination. Patients were not afraid of the manipulations, but of bleeding during the intervention
and in the postoperative period. While the medical
history, it was found that 11 (22.9%) patients of the
ﬁrst group noted prolonged bleeding, sometimes up
to 2 days, after previous dental interventions (tooth
extraction and professional oral hygiene). In two
cases (4.2%), it was precisely such type of bleeding
that was the ﬁrst manifestation of a disease of the
hematopoietic system two (4.2%) patients who
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Fig. 1. Tooth extraction with erbium laser and postoperative view. (A) Separation of a circular tooth ligament using radiation of the erbium laser with
the energy of 300 mJ and a frequency of 10 Hz without water-air cooling around the root of tooth 1.6. (B) Curettage of the socket of the extracted tooth
1.6 root using an erbium laser with the energy 250 mJ and frequency 15 Hz with water-air cooling. (C)The socket of the extracted tooth 1.6 root. (D)
The socket of the extracted tooth 1.6 root on the 3rd day after surgery.

underwent surgery were hospitalized with alveolar
socket bleeding for emergency medical care.
We observed unsatisfactory oral hygiene in all
patients with platelet hemostasis pathology since

they were afraid of trauma to the gingival mucosa
and subsequent bleeding during teeth brushing.
The characteristics of both groups are shown in
Table 2.

Table 2. Characteristics of hemostasis and age of patients in the 1st and 2nd groups.
Characteristic

1st group
Mean ± SD
(Median, Min-Max)

2nd group
Mean ± SD
(Median, Min-Max)

p

Age, years

44 ± 15.4
(42, 19-74)
70 ± 27
(65, 1-140)
7,6 ± 0.67
(6.6, 4.1-17)
5,38 ± 2.6
(5.35, 4.1-7.1)

47.6 ± 15.3
(49, 19-81)
304 ± 114
(315, 200-435)
-

>0.05

-

-

Trombocytes/mL
Morawitz coagulation time, min
Duke bleeding time, min
*SD-standard deviation, p-p-value.

<0.05
-
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Table 3. Characteristics of postoperative hemostasis in the 1st and 2nd groups.
Characteristic

1st group
Mean ± SD
(Median, Min-Max)

2nd group
Mean ± SD
(Median, Min-Max)

P

Hemostasis time after operation, sec

80.9 ± 35.9
(78, 15-175)
0.02 ± 0.14
(0, 0-1)

175 ± 67.5
(170, 95-300)
0
(0, 0)

<0.01

Postoperative bleeding, points

<0.05

Table 4. The distribution of study patients in the 1st and the 2nd groups according to the severity of pain in the postoperative period.
The severity of pain

Study group 1st
N (%)
Day 1

Day 3

Day 1

Day 3

Absence of pain
Lack of pain
Mild pain
Moderate pain
Severe pain
p-value

3 (6.3%)
24 (50%)
13 (27.1%)
5 (10,3%)
3 (6.3%)
<.001

34 (70.8%)
13 (27.1%)
1 (2.1%)
d
d

9 (18.8%)
14 (28.6%)
17 (35.9%)
8 (16.7%)

8 (16.7%)
24 (50%)
14 (28.6%)
2 (4.7%)
d

The platelet count in patients with thrombocytopenia ranged from single to 140,000/mL (70 ± 27). In
16 patients (33.3%), an increase in bleeding time
according to Duke was noted. Duke express test
results did not always correlate with platelet count,
which suggested that the risk of bleeding was often
due to functional platelet disorders. Conducting
express tests immediately before surgery allowed us
to assess the degree of violation of platelet-vascular
hemostasis at a given time.
Drug preparation before surgery was performed
only in 7 (14.6%) patients with pathology of platelet
hemostasis. In 3 (6.3%) of them, it consisted
comprised administering intravenous drugs before
surgical treatment because of severe thrombocytopenia against the background of ongoing chemotherapy and the urgency of the intervention. In 4
(8.3%) patients, drug preparation consisted of prescribing tablet forms of drugs (tranexamic acid) 3
days before surgical treatment and was due to a
high risk of bleeding associated with a severe degree of hematopoietic system pathology, which is a
manifestation of hemorrhagic syndrome.

Study group 2nd
N (%)

During surgery, in all cases, in patients with
platelet hemostasis disorders, increased bleeding
from the vessels of the microvasculature of the soft
tissues was deﬁned, and the severity of bleeding
was more often, but not always, correlated with the
number of platelets in the peripheral blood.
The use of an erbium laser made it possible to
achieve reliable hemostasis in all cases. The average
value of hemostasis time when using a laser was 80.9
± 35.9 seconds, the minimum and maximum values
were 15 seconds and 175 seconds, respectively. With
the traditional intervention technique, the average
hemostasis time was 175 ± 67.5 seconds, with the
minimum and maximum hemostasis times being 95
seconds and 300 seconds, respectively (p < 0.01).
Thus, when an erbium laser was used during the
intervention, bleeding stopped in a shorter time
than with the traditional method of intervention in
patients without pathology of the hematopoietic
system. No bleeding in the postoperative period was
observed, apart from 1 case (2,3%) associated with
violations of recommendations. Hemostasis was
monitored at the clinic for 40 minutes (Table 3).

Table 5. The distribution of study patients in the 1st and the 2nd groups according to the severity of edema in the postoperative period.
The severity of collateral edema

Study group 1st
N (%)

Study group 2nd
N (%)

Day 1

Day 3

Day 1

Day 3

Absence of edema
Lack of edema
Mild edema
Moderate edema
Severe edema
p-value

29 (60.4%)
13 (27.1%)
4 (8.3%)
1 (2.1%)
1 (2.1%)
<.001

40 (83.3%)
8 (16.7%)
d
d
d

4 (8.3%)
29 (60.4%)
12 (25%)
3 (6.3%)
d

4 (8.3%)
20 (41.2%)
10 (20.6%)
14 (29.9%)
d
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According to the results of the data obtained,
during operations performed using an erbium laser,
pain (Table 4) (H ¼ 88.8, p < 0.001) and collateral
edema (Table 5) (H ¼ 74.8, p < 0.001) were both less
pronounced on days 1 and 3 after surgery.
An important fact was that patients of the 1st group
did not take non-steroidal anti-inﬂammatory drugs
due to the absence of a pronounced pain syndrome,
which was especially important in patients with hemostatic disorders and in patients with erosive-ulcerative lesions of the gastrointestinal tract. It should
be noted that during surgical treatment with an
erbium laser, an increase in collateral edema from 1
to 3 operating days was not observed and an increase in edema was observed only in patients of the
control group. We had not found the correlation
between pain and edema in 2nd group (r ¼ 0.15, p >
0.05) with statistical signiﬁcance and found connection between these criteria in the 1st group (r ¼ 0.54,
p < 0.05). There was no correlation between time
bleeding according to Duke and edema on the day 1
after operation in the 1st group (r ¼ 0.14, p > 0.05).
The correlation between Morawitz time coagulation
and edema on the day 1 after operation was rather
weak (r ¼ 0.29, p < 0.05). The correlation between the
number of thrombocytes in the patients of the 1st
group and postoperative bleeding was not signiﬁcant (r ¼ 0.11, p > 0.05).
We also noted faster epithelization of wounds and
sockets in this group of patients (on average, 2 days
faster than in the 2nd group), without signs of
inﬂammation and without scar formation, despite
the fact that in patients with diseases of the hematopoietic system, repair and regeneration potentials were reduced due to the concomitant
pathology itself and the use of drugs prescribed for
its treatment and correction of the condition.

4. Discussion
When providing surgical dental care to patients
with platelet hemostasis disorders, an assessment of
the risk of intra- and postoperative bleeding development is relevant. Several authors described
various algorithms for preparing such patients for
dental treatment - the use of thrombopoiesis stimulants and preparation using corticosteroid drugs
[34-36]. It is recommended to perform simple tooth
extraction with a platelet count of more than 30,000/
mL, and more complex surgical interventions may be
conducted with a platelet count of more than 50,000/
mL [34,35]. However, these solutions require time
and dynamic control of platelet count and their

BioMedicine
2021;11(2):47e54

functional activity. At the same time, in oral surgery,
we often encounter acute pain complaints and we
need to perform surgical procedures without prolonged medical preparation.
Algorithms for assisting this group of patients and
the results of studies conducted in this direction
indicate the frequent need for surgical dental interventions in a hospital setting [34,35].
To optimize the care of patients with this pathology, we evaluated the possibility of using laser
technologies on them. Dissecting the tissue, the
laser beam simultaneously coagulates the vessels on
the walls of the wound, contributing to hemostasis.
In addition, postoperative edema is minimal, the
intensity of intraoperative and postoperative pain is
reduced, and patients do not experience psychoemotional stress [36-43].
In several studies, the opportunity of diodeportunity of diode and Nd: YAG laser was shown to
stimulate periodontal regeneration of the tissues
during the operation of tooth transplantation on the
cell level because the increase in calcium deposit in
osteoblasts and collagen in the ﬁbroblasts leads to
decrease in the time of wound healing [44].
There are no clinical studies on the use of erbium
laser in the treatment of dental patients with the
impaired hemostasis, but there are several studies
in vivo; for example, Campos et al. (2018) compared
the results of the use of high-power lasers and
traditional scalpel in the rats after the administration of anticoagulants and created conditions of
intensive bleeding during frenectomy of tongue that
was completely solved with the laser radiation [30].
The same scientists pointed to the lack of evidence
of basic information on the use of any lasers in patients with intra- and postoperative high risk of
bleeding during oral surgery. Despite the possible
priority of the laser energy for hemostasis, the
complicity of tooth extraction in patients includes
possible bleeding not only from soft tissues but also
from the bottom and alveolar walls, which require
other working modes of laser.
The use of erbium can signiﬁcantly reduce the risk
of late bleeding in patients with impaired platelet
hemostasis, making it possible to carry out surgical
manipulation in an outpatient dental setting without
prolonged medical preparation and provide stimulation of alveolar epithelization and reduce the
number of pathogenic microorganisms. In some
cases, the use of an erbium laser successfully solves
the problem of providing emergency surgical dental
care even in patients with resistant forms of the

disease and the manifestation of hemorrhagic syndrome [45-49].
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